---
layout: full_article
title: "Meta analisis perbandingan luaran prosedur tubeless dan totally tubeless dibandingkan dengan prosedur nefrostomi pasca tindakan percutaneous nephrolithotomy"
author: "Anak Agung Gde Oka"
categories: eum
comments: true
---

<div><img src="https://jurnal.harianregional.com/media/64333-1.jpg" alt="" style="width:133pt;height:75pt;">
</div><br clear="all">
<p><span class="font5">ISSN: 2597-8012 JURNAL MEDIKA UDAYANA, VOL. 9 NO10,OKTOBER, 2020</span></p>
<div><img src="https://jurnal.harianregional.com/media/64333-2.jpg" alt="" style="width:69pt;height:17pt;">
</div><br clear="all">
<div><img src="https://jurnal.harianregional.com/media/64333-3.jpg" alt="" style="width:90pt;height:15pt;">
</div><br clear="all">
<p><span class="font1" style="text-decoration:underline;">Diterima:08-09-2020 Revisi:12-09-2020 Accepted: 22-10-2020</span></p><a name="caption1"></a>
<h1><a name="bookmark0"></a><span class="font8" style="font-weight:bold;"><a name="bookmark1"></a>META ANALISIS PERBANDINGAN LUARAN PROSEDUR </span><span class="font8" style="font-weight:bold;font-style:italic;">TUBELESS</span><span class="font8" style="font-weight:bold;"> DAN </span><span class="font8" style="font-weight:bold;font-style:italic;">TOTALLY TUBELESS</span><span class="font8" style="font-weight:bold;"> DIBANDINGKAN DENGAN PROSEDUR NEFROSTOMI PASCA TINDAKAN </span><span class="font8" style="font-weight:bold;font-style:italic;">PERCUTANEOUS NEPHROLITHOTOMY</span></h1>
<p><span class="font6" style="font-weight:bold;">Anak Agung Gde Oka</span><span class="font6" style="font-style:italic;">.</span></p>
<h2><a name="bookmark2"></a><span class="font7"><a name="bookmark3"></a>Departemen Urologi, Fakultas Kedokteran Universitas Udayana / RSUP Sanglah Koreponding author: </span><span class="font6">Anak Agung Gde Oka</span></h2>
<p><span class="font6">E-mail:</span><a href="mailto:aag.oka@unud.ac.id"><span class="font6"> </span><span class="font6" style="text-decoration:underline;">aag.oka@unud.ac.id</span></a></p>
<p><span class="font6" style="font-weight:bold;">ABSTRAK</span></p>
<p><span class="font6">Pemasangan nefrostomi pada pasien pasca tindakan </span><span class="font6" style="font-style:italic;">percutaneous nephrolithotomy</span><span class="font6"> (PNL) merupakan prosedur tindakan standar yang dilakukan saat ini, namun beberapa tahun terakhir banyak penelitian yang melaporkan penggunaan prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> pasca tindakan PNL dengan hasil yang memuaskan. Penelitian ini bertujuan untuk mengevaluasi keamanan dan luaran prosedur </span><span class="font6" style="font-style:italic;">tubeless </span><span class="font6">PNL dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> PNL dibandingkan dengan prosedur standar (nefrostomi) pasca PNL. Database </span><span class="font6" style="font-style:italic;">Medline</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">Cochrane Library</span><span class="font6"> digunakan untuk mencari penelitian-penelitian </span><span class="font6" style="font-style:italic;">randomized controlled trials </span><span class="font6">(RCTs) yang membandingkan luaran pada pasien-pasien yang dilakukan prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dibandingkan dengan prosedur standar pasca PNL. Luaran yang dianalisis pada penelitian ini adalah lama rawat, penurunan hemoglobin (Hb), serta kebutuhan terapi analgesia pasca tindakan PNL. Studi meta-analisis ini dikaji dengan menggunakan piranti lunak </span><span class="font6" style="font-style:italic;">Review Manager</span><span class="font6"> 5.0. Sebelas penelitian RCTs dianalisis dengan total pasien sebanyak 806 dan terdiri dari 9 penelitian RCTs pada perbandingan pertama (</span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> vs nefrostomi, 290 kasus dan 295 kontrol) dan 2 penelitian RCTs pada perbandingan kedua (</span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> vs nefrostomi, 113 kasus dan 108 kontrol). Grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> memberikan perbedaan hasil yang signifikan pada lama rawat dan kebutuhan analgesia dibandingkan dengan grup nefrostomi pasca PNL. Grup </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> menunjukkan perbedaan yang signifikan pada lama rawat dibandingkan dengan grup nefrostomi pasca PNL. Tidak ada perbedaan tingkat penurunan Hb pada kedua perbandingan tersebut. Prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> lebih superior dibandingkan dengan prosedur nefrostomi pasca PNL dalam hal lama rawat. Prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> juga berasosiasi dengan lebih rendahnya kebutuhan analgesia dibandingkan dengan prosedur nefrostomi pasca PNL.</span></p>
<p><span class="font6" style="font-weight:bold;font-style:italic;">Kata kunci : percutaneous nephrolitotomy (PNL), tubeless, nefrostomi</span></p>
<p><span class="font6" style="font-weight:bold;">ABSTRACT</span></p>
<p><span class="font6">Percutaneous nephrolithotomy (PNL) with nephrostomy tube as a drainage has been considered the standard procedure. However, recently many literatures reporting the use of tubeless and totally tubeless as a drainage following PCNL with excellent results. This meta-analysis aimed to evaluate the safety of tubeless PCNL and totally tubeless PCNL versus nephrostomy tube as a drainage following PNL. All eligible literatures were searched on MEDLINE and Cochrane Library database to identify all randomized controlled trials (RCTs) that compared tubeless and totally tubeless PNL versus nephrostomy tube following PNL. The analyzed outcomes were length of hospital stay, postoperative hemoglobin (Hb) drop, and postoperative analgesic requirements. Review Manager 5.0. was used to conduct the meta-analysis study. Eleven RCTs covering 806 subjects and consist of 9 RCTs for comparison I (tubeless PCNL vs nephrostomy tube PNL, 290 cases and 295 controls) and 2 RCTs for comparison II (totally </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> PNL vs nephrostomy tube PNL, 113 cases and 108 controls) were identified. Tubeless PNL required significantly less analgesic and shorter length of hospital stay compared with nephrostomy tube PNL. Furthermore, there was shorter length of hospital stay in totally tubeless PNL compared with nephrostomy tube PNL. However, no significant difference was observed in the analyses concerning postoperative Hb decrease in </span><a href="https://ojs.unud.ac.id/index.php/eum"><span class="font6">https://ojs.unud.ac.id/index.php/eum</span></a><span class="font6"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="font6" style="font-weight:bold;">1</span></p>
<p><span class="font6">doi:10.24843.MU.2020.V9.i10.P01</span></p>
<div>
<p><span class="font6">both comparisons. Tubeless PNL and totally tubeless PNL are associated with shorter hospital stay compared with nephrostomy tube PNL. Tubeless PNL also associated with less analgesic requirement compared with nephrostomy tube PNL.</span></p>
<p><span class="font6" style="font-weight:bold;">Keywords : percutaneous nephrolithotomy, tubeless, nephrostomy</span></p>
<p><span class="font6">Studi-studi yang masuk ke dalam penelitian ini </span><span class="font6" style="font-weight:bold;">PENDAHULUAN &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="font6">memiliki kriteria inklusi: harus studi RCTs, dimana</span></p>
</div><br clear="all">
<p><span class="font6" style="font-style:italic;">Percutaneous nephrolithotomy</span><span class="font6"> (PNL) merupakan tatalaksana utama dalam penanganan pasien dengan batu ginjal yang besar.<sup>1 </sup>Perkembangan teknik PNL mencetuskan inovasi-inovasi baru pada prosedur PNL yang bertujuan untuk keamanan dan kenyaman pasien.<sup>2</sup> Rupel dan Brown melaporkan penanganan batu ginjal dengan cara mengambil batu ginjal via nefrostomi pada tahun 1941<sup>2</sup> namun baru pada tahun 1976 prosedur PNL menjadi terkenal saat Fernstrom dan Johannson melakukan tindakan pengambilan batu ginjal melalui cara perkutan.<sup>2</sup></span></p>
<p><span class="font6">Pemasangan nefrostomi pasca PNL sebagai tindakan drainase masih merupakan suatu prosedur yang standar. Selain bertujuan sebagai drainase, pemasangan nefrostomi pasca PNL juga dapat bertujuan untuk: media tampon bila terjadi perdarahan pasca PNL, fasilitas akses apabila diperlukan prosedur </span><span class="font6" style="font-style:italic;">second-look</span><span class="font6">, dan menjadi akses bila kemolisis perkutan diperlukan.<sup>3 </sup>Belakangan ini banyak studi yang melaporkan prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> pasca PNL dengan hasil yang memuaskan. Hal ini menyebabkan terjadinya kontroversi mengenai prosedur yang harus dikerjakan pasca PNL dengan mengedepankan kemanan dan kenyamanan pasien.</span></p>
<p><span class="font6">Tujuan dari penelitian ini adalah untuk mengevaluasi keamanan prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dibandingkan dengan nefrostomi pasca PNL dengan melakukan studi meta analisis pada penelitian-penelitian RCTs.</span></p>
<p><span class="font6" style="font-weight:bold;">METODE</span></p>
<p><span class="font6">Penulis melakukan pencarian literatur-literatur yang dipublikasi hingga bulan Juli 2015 melalui database elektronik (</span><span class="font6" style="font-style:italic;">Medline</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">Cochrane Library</span><span class="font6">) menggunakan kata kunci: </span><span class="font6" style="font-style:italic;">stone, percutaneous nephrolithotomy, tubeless, nephrostomy</span><span class="font6">. Pencarian literatur tidak dibatasi oleh bahasa pada penelitian tersebut dan jenis penelitian yang dilakukan.</span></p>
<p><span class="font6">semua RCTs tersebut membandingkan luaran </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan nefrostomi dan/atau </span><span class="font6" style="font-style:italic;">totally tubeless </span><span class="font6">dan nefrostomi pasca PNL. Karakteristik dasar pasien-pasien dari dua grup harus seimbang dan jumlah subyek, rerata, dan standar deviasi harus dicantumkan. Analisis luaran adalah hal-hal yang berkaitan dengan keamanan pasca PNL. Luaran yang dianalisis pada penelitian ini adalah lama rawat, penurunan Hb pasca-operasi, dan kebutuhan analgesia pasca-operasi.</span></p>
<p><span class="font6">Meta analisis pada penelitian ini menggunakan piranti lunak </span><span class="font6" style="font-style:italic;">Review Manager 5.0</span><span class="font6">. Seluruh variable kontinyu dibandingkan melalui MD (</span><span class="font6" style="font-style:italic;">mean difference</span><span class="font6">/perbedaan rerata) dengan 95% CI (</span><span class="font6" style="font-style:italic;">confidence interval</span><span class="font6">/interval kepercayaan). Efek dari tindakan disajikan sebagai grup eksperimental rasio (</span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> atau </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6">) dibandingkan dengan grup control (nefrostomi). Heterogenitas antara penelitian diukur menggunakan tes chi kuadrat dengan nilai p &lt;&nbsp;0,05 dianggap heterogen. Heterogenitas juga dinilai dengan ukuran I kuadrat. </span><span class="font6" style="font-style:italic;">Fixed effect model </span><span class="font6">digunakan untuk analisis pada data yang homogen sedangkan </span><span class="font6" style="font-style:italic;">random effect model</span><span class="font6"> digunakan untuk analisis pada data yang heterogen. Seluruh analisis disajikan menggunakan </span><span class="font6" style="font-style:italic;">forest plot</span><span class="font6">. Penelitian meta analisis ini tidak memerlukan </span><span class="font6" style="font-style:italic;">ethical clearance </span><span class="font6">dari komisi etik lokal.</span></p>
<p><span class="font6" style="font-weight:bold;">HASIL</span></p>
<p><span class="font6">Sebanyak 201 penelitian ditemukan pada tahap pencarian pertama. Sebanyak 188 literatur dieksklusi dengan memperhatikan judul dan abstrak. Setelah melakukan pengkajian terhadap sisa dari studi-studi tersebut (13 studi), sebanyak 2 studi dieksklusi oleh karena karakteristik pasien yang tidak relevan. Total sebanyak 11 studi diteliti pada meta analisis ini. Proses skrining dari literatur ditunjukkan pada Gambar 1.</span></p><img src="https://jurnal.harianregional.com/media/64333-4.jpg" alt="" style="width:210pt;height:98pt;">
<p><span class="font6" style="font-weight:bold;">Gambar 1. </span><span class="font6">Proses pencarian literatur</span></p>
<p><span class="font6">Karakteristik pasien pada seluruh studi yang dianalisis pada meta analisis ditunjukkan pada Tabel 1. Sebelas penelitian RCTs dengan total 806 subyek dan terdiri dari perbandingan pertama (</span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> PNL vs nefrostomi PNL, 290 kasus dan 295 kontrol) dan dua RCTs untuk perbandingan kedua (</span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> PNL vs nefrostomi PNL, 113 kasus dan 108 kontrol). Dari 9 studi pada perbandingan pertama, 4 studi menggunakan DJ-stent 6 Fr, satu studi menggunakan DJ-stent 7 Fr, tiga studi menggunakan ureter kateter, dan satu studi menggunakan DJ stent tanpa mencantumkan ukuran. Ukuran nefrostomi yang digunakan berkisar antara 8 Fr hingga 22</span></p>
<p><span class="font6">Sebelas studi melaporkan lama rawat inap<sup>4-14 </sup>namun satu studi &nbsp;dieksklusi &nbsp;karena tidak</span></p>
<p><span class="font6">mencantumkan standar deviasi. Perbandingan lama rawat inap pada grup t</span><span class="font6" style="font-style:italic;">ubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless </span><span class="font6">dibandingkan dengan nefrostomi diperlihatkan pada Tabel 2. Sepuluh studi dianalisis dengan total 774 pasien.<sup>4-11,13,14</sup> Lama rawat inap pasien pasca PNL pada grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> lebih singkat secara signifikan dibandingkan grup nefrostomi (MD = -0,83; KI 95% -1,22 – (-0,45); p &lt;&nbsp;0,001) dengan I kuadrat sebesar 89%. Pada analisis subgroup, grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> menunjukkan lama rawat yang lebih singkat dibandingkan dengan grup nefrostomi (MD = 0,80; KI 95% -1,26 – (-0,35); p = 0,0005) dengan I kuadrat sebesar 90%. Hal yang sama juga ditemukan pada grup </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6">, dimana grup ini menunjukkan lama rawat inap yang lebih singkat dibandingkan grup nefrostomi (MD = 0,94; KI 95% -1,70 – (-0,18); p = 0,02) dengan I kuadrat sebesar 77%. Analisis luaran ditampilkan dalam forest plot pada Gambar 2.</span></p>
<p><span class="font6">Sebanyak 8 studi melaporkan keadaan Hb pasien pasca PNL dengan total pasien berjumlah 677.<sup>4,8-14</sup> Forest plot menunjukkan bahwa</span></p>
<div>
<p><span class="font6" style="font-weight:bold;">Tabel 1. </span><span class="font6">Karakteristik studi pada meta analisis</span></p>
<table border="1">
<tr><td rowspan="2" style="vertical-align:top;">
<p><span class="font4">Penulis utama (tahun)</span></p></td><td rowspan="2" style="vertical-align:top;">
<p><span class="font4">Desain studi</span></p></td><td style="vertical-align:top;">
<p><span class="font4">Jumlah pasien</span></p></td><td colspan="2" style="vertical-align:bottom;">
<p><span class="font4">Umur (tahun) (rerata </span><span class="font4" style="text-decoration:underline;">+ </span><span class="font4">simpang baku)</span></p></td><td colspan="2" style="vertical-align:bottom;">
<p><span class="font4">Besar batu (rerata </span><span class="font4" style="text-decoration:underline;">+ </span><span class="font4">simpang baku)</span></p></td><td rowspan="2" style="vertical-align:top;">
<p><span class="font4" style="font-style:italic;">Tubeless</span></p></td><td rowspan="2" style="vertical-align:top;">
<p><span class="font4">Ukuran nefrostomi</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">Eksperimental &nbsp;&nbsp;Kontrol</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Eksperimental</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Kontrol</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Eksperimental</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Kontrol</span></p></td></tr>
<tr><td colspan="2" style="vertical-align:bottom;">
<p><span class="font4" style="font-style:italic;">Tubeless</span><span class="font4"> (eksperimental)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">vs nefrostomi (kontrol) PNL</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font4">Agrawal</span></p></td><td style="vertical-align:top;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:top;">
<p><span class="font4">101 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;101</span></p></td><td style="vertical-align:top;">
<p><span class="font4">33</span></p></td><td style="vertical-align:top;">
<p><span class="font4">31</span></p></td><td style="vertical-align:top;">
<p><span class="font4">3,8 cm<sup>2</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font4">3,6 cm<sup>2</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font4">DJ-stent</span></p></td><td style="vertical-align:top;">
<p><span class="font4">16 Fr</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">(2008)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font4">Choi</span></p></td><td style="vertical-align:top;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:top;">
<p><span class="font4">12 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12</span></p></td><td style="vertical-align:top;">
<p><span class="font4">52,9 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 14</span></p></td><td style="vertical-align:top;">
<p><span class="font4">47 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 16</span></p></td><td style="vertical-align:top;">
<p><span class="font4">28,5 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 15,4</span></p></td><td style="vertical-align:top;">
<p><span class="font4">26,8 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:top;">
<p><span class="font4">6 Fr DJ-</span></p></td><td style="vertical-align:top;">
<p><span class="font4">8,2 Fr</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">(2006)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">mm</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">13,5</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">stent</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">mm</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">Desai</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">10 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">41,1</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">43,4</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">249,1 mm<sup>2</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font4">263,7</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">6 Fr DJ-</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">20 Fr</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">(2004)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">mm<sup>2</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font4">stent</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">Marchant</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">40 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">52,8 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 12,5</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">47,2 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">6,4 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 3,0 cm<sup>2</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font4">7,8 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">7 Fr DJ-</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">18 Fr</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">(2011)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">10,1</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">4,8 cm<sup>2</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font4">stent</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Mishra</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">11 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">42,3 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 8,6</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">42,5 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">2934,2 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">2737 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">Ureteral</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">20 Fr</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">(2010)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">7,8</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">2090,7 mm<sup>3</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font4">946,9</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">kateter</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;"><sub>mm</sub></span><span class="font2">3</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Shah</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">33 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">44,18 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 13,13</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">46,69 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">535,36 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">495,91</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">6 Fr DJ-</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">8 Fr</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">(2008)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">18,46</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">543,39 mm<sup>2</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">stent</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">445,92</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font4">mm<sup>2</sup></span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">Shoma</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">50 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">48,66</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">42,08</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">1226 mm<sup>2</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font4">1004</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Ureteral</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">22 Fr</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">(2012)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font0" style="font-weight:bold;"><sub>mm</sub></span><span class="font2">2</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">kateter</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Tefekli</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">17 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">38,4 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 12,3</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">41,3 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">3,0 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,7 cm<sup>2</sup></span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">3,1 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">Ureteral</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">14 Fr</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">(2007)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font4">14,7</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font4">0,9 cm<sup>2</sup></span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">kateter</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">Lu</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">16 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">43,81 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 18,89</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">46,25 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">3,11 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,62</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">3,29 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">6 Fr DJ-</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">16 Fr</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">(2012)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">22,37</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">cm</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">0,54</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">stent</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">cm</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td colspan="4" style="vertical-align:bottom;">
<p><span class="font4" style="font-style:italic;">Totally tubeless</span><span class="font4"> (eksperimental) vs nefrostomi (kontrol) PNL</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font4">Chang</span></p></td><td style="vertical-align:top;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:top;">
<p><span class="font4">68 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;63</span></p></td><td style="vertical-align:top;">
<p><span class="font4">59,22 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 12,44</span></p></td><td style="vertical-align:top;">
<p><span class="font4">58,70 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:top;">
<p><span class="font4">24,74 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 2,69</span></p></td><td style="vertical-align:top;">
<p><span class="font4">24,86 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">-</span></p></td><td style="vertical-align:top;">
<p><span class="font4">20 Fr</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">(2011)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">10,85</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">mm</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">2,78</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">mm</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">Istanbulluoglu</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">RCT</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">45 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">47,48 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 13,04</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">43,91 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">448,93 </span><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">453,35</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">14 Fr</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">(2009)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">14,44</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">249,13 mm<sup>2</sup></span></p></td><td style="vertical-align:middle;">
<p><span class="font4" style="text-decoration:underline;">+</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td colspan="2" style="vertical-align:middle;">
<p><a href="https://ojs.unud.ac"><span class="font6">https://ojs.unud.ac</span></a><span class="font6">.</span></p></td><td style="vertical-align:middle;">
<p><span class="font6">id/index.php/eum</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font4">165,97 mm<sup>2</sup></span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font6" style="font-weight:bold;">3</span></p></td></tr>
<tr><td colspan="3" style="vertical-align:bottom;">
<p><span class="font4">0/12/1Q λ∕ΠT 0∩0∩ AZG i 1∩ D∩1</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td colspan="3" style="vertical-align:top;">
<p><span class="font6" style="font-style:italic;">RCT = Randomized controlled trial</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
</table>
</div><br clear="all">
<p><span class="font6">penurunan Hb pasca PNL tidak berbeda signifikan antara grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless </span><span class="font6">dibandingkan dengan grup nefrostomi (MD = -0,03; IK 95% -0,08 – 0,02; p = 0,22) dengan derajat I kuadrat sebesar 39%. Berdasarkan analisis subgroup, tingkat penurunan Hb pasca PNL tidak berbeda signifikan antara grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan grup nefrostomi (MD = -0,02; IK 95% -0,07 – 0,03; p = 0,33) dengan I kuadrat sebesar 54%. Tingkat penurunan Hb pasca PNL juga tidak berbeda secara signifikan antara grup </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dan grup nefrostomi (MD = -0,09; IK 95% -0,25 – 0,07; p = 0,28) dengan I kuadrat sebesar 0%. Hasil forest plot ditunjukkan pada gambar 3.</span></p>
<p><span class="font6" style="font-weight:bold;">Tabel 2. </span><span class="font6">Lama rawat inap prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dibandingkan dengan nefrostomi pasca PNL</span></p>
<table border="1">
<tr><td rowspan="2" style="vertical-align:top;">
<p><span class="font4">Penulis utama (tahun)</span></p></td><td colspan="2" style="vertical-align:top;">
<p><span class="font4">Lama rawat (umur)</span></p></td><td rowspan="2" style="vertical-align:top;">
<p><span class="font4">nilai </span><span class="font4" style="font-style:italic;">p</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font4">Eksperimental</span></p></td><td style="vertical-align:top;">
<p><span class="font4">Kontrol</span></p></td></tr>
<tr><td colspan="3" style="vertical-align:bottom;">
<p><span class="font4" style="font-style:italic;">Tubeless</span><span class="font4"> (eksperimental) vs nefrostomi (kontrol) PNL</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Agrawal (2008)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">0,91 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,16</span></p></td><td style="vertical-align:top;">
<p><span class="font4">2,26 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,21</span></p></td><td style="vertical-align:top;">
<p><span class="font4">&lt; 0,01</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Choi</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">1,55 + 0,988</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">1,6 + 1,01</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font4">0,903</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">(2006)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Desai (2004)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">3,4 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,5</span></p></td><td style="vertical-align:top;">
<p><span class="font4">4,4 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,8</span></p></td><td style="vertical-align:top;">
<p><span class="font4">&lt; 0,05</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Marchant (2011)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">3,2 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,7</span></p></td><td style="vertical-align:top;">
<p><span class="font4">5,0 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 2,8</span></p></td><td style="vertical-align:top;">
<p><span class="font4">0,001</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Mishra (2010)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">2,93 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,77</span></p></td><td style="vertical-align:top;">
<p><span class="font4">3,03 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,09</span></p></td><td style="vertical-align:top;">
<p><span class="font4">0,09</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Shah (2008)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">1,45 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,46</span></p></td><td style="vertical-align:top;">
<p><span class="font4">1,83 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,9</span></p></td><td style="vertical-align:top;">
<p><span class="font4">0,036</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">Shoma (2012)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">2,71 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 2,04</span></p></td><td style="vertical-align:top;">
<p><span class="font4">3,25 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 1,92</span></p></td><td style="vertical-align:top;">
<p><span class="font4">0,16</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Tefekli (2007)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">1,6 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,4</span></p></td><td style="vertical-align:top;">
<p><span class="font4">2,8 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,9</span></p></td><td style="vertical-align:top;">
<p><span class="font4">&lt; 0,05</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Lu (2012)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">3 (2-7)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">4 (3-12)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">0,032</span></p></td></tr>
<tr><td colspan="2" style="vertical-align:bottom;">
<p><span class="font4" style="font-style:italic;">Totally tubeless</span><span class="font4"> (eksperimental)</span></p></td><td colspan="2" style="vertical-align:bottom;">
<p><span class="font4">vs nefrostomi (kontrol) PNL</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Chang (2011)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">3,60 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 0,98</span></p></td><td style="vertical-align:top;">
<p><span class="font4">4,19 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 1,23</span></p></td><td style="vertical-align:top;">
<p><span class="font4">0,003</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">Instanbul Luoglu (2009)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">2,11 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 1,13</span></p></td><td style="vertical-align:top;">
<p><span class="font4">3,48 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 1,68</span></p></td><td style="vertical-align:top;">
<p><span class="font4">0,01</span></p></td></tr>
</table>
<p><span class="font6">Tingkat kebutuhan analgesia pasca PNL dilaporkan pada 8 studi<sup>4-6,8-11,14</sup> yang ditunjukkan pada Tabel 3. Sebanyak 4 studi dengan total 220 pasien menggunakan diclofenac sebagai analgesia pasca PNL.<sup>6,9-11</sup> Grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> membutuhkan lebih sedikit analgesia dibandingkan grup nefrostomi pasca operasi (MD = -82,26; IK 95% -134,49 – (30,02); p = 0,002) dengan I kuadrat sebesar 85%, yang ditunjukkan pada Gambar 4.</span></p>
<p><span class="font6" style="font-weight:bold;">Tabel 3. </span><span class="font6">Kebutuhan analgesia postoperatif pada prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless </span><span class="font6">dibandingkan dengan nefrostomi pasca PNL</span></p>
<p><span class="font4">Penulis &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kebutuhan analgesia</span></p>
<p><span class="font4">utama &nbsp;&nbsp;&nbsp;&nbsp;Analgesia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="font4" style="text-decoration:underline;">(mg)</span><span class="font4"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;nilai </span><span class="font4" style="font-style:italic;">p</span></p>
<p><span class="font4">(tahun) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eksperimental Kontrol</span></p>
<p><span class="font4" style="font-style:italic;">Tubeless</span><span class="font4"> (eksperimental) vs nefrostomi (kontrol) PNL</span></p>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font4">Desai (2004)</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Diclofenac</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">87,5 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 55,8</span></p></td><td style="vertical-align:top;">
<p><span class="font4">217,5 </span><span class="font4" style="text-decoration:underline;">+ </span><span class="font4">59</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">0,38</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font4">Shah (2008)</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Diclofenac</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">150,00 </span><span class="font4" style="text-decoration:underline;">+ </span><span class="font4">97,42</span></p></td><td style="vertical-align:top;">
<p><span class="font4">246,09 </span><span class="font4" style="text-decoration:underline;">+ </span><span class="font4">167,41</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">0,006</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font4">Shoma (2012)</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Diclofenac</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">30 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 48</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">57 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 58</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">0,013</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Tefekli (2007)</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Diclofenac</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">110,3 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 52,2</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">200,0 </span><span class="font4" style="text-decoration:underline;">+ </span><span class="font4">66,1</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">&lt; 0,05</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Mishra (2010)</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Tramadol</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">68,2 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 46,2</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">72,7 </span><span class="font4" style="text-decoration:underline;">+</span></p>
<p><span class="font4">51,8</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">0,25</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">Choi (2006)</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Morphine</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">1,91 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 2,5</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">3,60 </span><span class="font4" style="text-decoration:underline;">+</span></p>
<p><span class="font4">4,63</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">0,28</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font4">Agrawal (2008)</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">Meperidine</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">81,7 </span><span class="font4" style="text-decoration:underline;">+</span><span class="font4"> 24,5</span></p></td><td style="vertical-align:top;">
<p><span class="font4">126,5 </span><span class="font4" style="text-decoration:underline;">+</span></p>
<p><span class="font4">33,3</span></p></td><td style="vertical-align:middle;">
<p><span class="font4">&lt; 0,01</span></p></td></tr>
<tr><td colspan="5" style="vertical-align:bottom;">
<p><span class="font4" style="font-style:italic;">Totally tubeless</span><span class="font4"> (eksperimental) vs nefrostomi (kontrol) PNL</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font4">23 dari</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font4">Instanbull</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font4">15 dari 45</span></p></td><td style="vertical-align:top;">
<p><span class="font4">45</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font4">uoglu</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">Meperidine</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">pasien</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">pasien</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">0,004</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font4">(2009)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font4">(50 – 150)</span></p></td><td style="vertical-align:top;">
<p><span class="font4">(50 –</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font4">150)</span></p></td><td style="vertical-align:top;"></td></tr>
</table>
<p><span class="font6" style="font-weight:bold;">DISKUSI</span></p>
<p><span class="font6">PNL masih merupakan pilihan utama pada penatalaksanaan pasien dengan batu ginjal yang besar.<sup>3,15</sup> Keputusan pemakaian nefrostomi pasca PNL tergantung pada beberapa faktor, yaitu masih terdapat sisa batu, akses untuk prosedur </span><span class="font6" style="font-style:italic;">second-look</span><span class="font6">, perdarahan intra-operatif, ekstravasasi urin, obstruksi ureter, dan kemolitolisis secara perkutan.<sup>3 </sup>Nefrostomi biasanya dipasang diakhir prosedur pada luka operasi yang sama dan nefrostomi diletakkan pada sistem pelviokalises ginjal. Namun belakangan ini banyak studi yang melaporkan kelebihan dari prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dibandingkan dengan nefrostomi pasca PNL.</span></p>
<p><span class="font6">Sebanyak 9 studi melaporkan perbandingan lama rawat pada grup </span><span class="font6" style="font-style:italic;">tubeless </span><span class="font6">dibandingkan dengan grup nefrostomi post PNL, dimana sebanyak 6 studi melaporkan bahwa lama rawat grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> lebih singkat dibandingkan dengan grup nefrostomi.<sup>4,6,7,9,11,12</sup> Studi lainnya melaporkan lama rawat grup </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> lebih singkat dibandingkan dengan grup nefrostomi.<sup>13,14 </sup>Penelitian meta analisis ini menunjukkan bahwa lama rawat pasien pada grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> lebih singkat dibandingkan dengan grup nefrostomi. Analisis subgrup juga menunjukkan</span></p>
<p><span class="font6">bahwa grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> lebih baik dari grup nefrostomi dari lama rawat inap pasca operasi.</span></p>
<p><span class="font6">Hb di grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless </span><span class="font6">dibandingkan dengan grup nefrostomi pada seluruh studi yang melaporkan penurunan Hb pasca PNL.<sup>4,8-14</sup> Studi meta analisis ini menunjukkan</span></p>
<div>
<p><span class="font0" style="font-weight:bold;">Experimental Control</span></p>
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;">Mean Difference &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mean Difference</span></p>
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;">IV, Random, 95% Cl</span></p>
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;text-decoration:underline;">StudyorSubgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl </span><span class="font0" style="font-weight:bold;">1.1.1 Tubeless vs NephrostomyTube</span></p>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Agrawal 2008</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.91</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.16</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">101</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">2.26</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.21</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">101</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">12.6%</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">-1.35 [-1.40, -1.30]</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Choi 2006</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.5S</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.99</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">12</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.6</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.01</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">12</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">8.1%</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">-0.05 [-0.85, 0.75]</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">Desai 2004</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">3.4</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">0.5</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">10</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">4.4</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">0.8</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">10</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">9.7%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">-1.00 [-1.58, -0.42]</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">Marchant 2011</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">3.2</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">0.7</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">40</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">5</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">2.8</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">45</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">7.8%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">-1.80 [-2.65, -0.95]</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Mishra 2010</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">2.93</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.77</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">11</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">3.03</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.09</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">11</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">10.7%</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">-0.10 [-0.56, 0.36]</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Shah 2008</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.45</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.46</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">33</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.83</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.9</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">32</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">11.4%</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">-0.38 [-0.73, -0.03]</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">Shoma 2012</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">2.71</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">2.04</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">50</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">3.25</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">1.92</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">50</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">8.3%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">-0.54 [-1.32, 0.24]</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Tefekli 2007</span></p>
<p><span class="font0" style="font-weight:bold;">Subtotal (95% Cl)</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.6</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.4</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">17</span></p>
<p><span class="font0" style="font-weight:bold;">2 74</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">2.8</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.9</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">18</span></p>
<p><span class="font0" style="font-weight:bold;">279</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">10.7%</span></p>
<p><span class="font0" style="font-weight:bold;">79.4%</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">-1.20 [-1.66, -0.74]</span></p>
<p><span class="font0" style="font-weight:bold;">-0.80 (-1.26, -0.35)</span></p></td></tr>
</table>
<p><span class="font0" style="font-weight:bold;">Heterogeneity: Tau<sup>2</sup> = 0.3 5; Chi<sup>3</sup> = 7 2.2 2, df = 7 (P &lt;&nbsp;0.00001); I<sup>3</sup> = 90%</span></p>
<p><span class="font0" style="font-weight:bold;">Test for overall effect: Z = 3.46 (P = 0.0005)</span></p>
</div><br clear="all">
<div><img src="https://jurnal.harianregional.com/media/64333-5.jpg" alt="" style="width:37pt;height:12pt;">
</div><br clear="all">
<div><img src="https://jurnal.harianregional.com/media/64333-6.jpg" alt="" style="width:36pt;height:38pt;">
</div><br clear="all">
<ul style="list-style:none;"><li>
<p><span class="font0" style="font-weight:bold;">1.1.2 Totally Tubeless vs Nephrostomy Tube Chang 2011 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.6 0.98 &nbsp;&nbsp;68 &nbsp;4.19 1.23 &nbsp;&nbsp;63 &nbsp;11.2%</span></p>
<div>
<p><span class="font0" style="font-weight:bold;">-0.59 [-0.97, -0.21]</span></p>
<p><span class="font0" style="font-weight:bold;">-1.37 [-2.00, -0.74]</span></p>
<p><span class="font0" style="font-weight:bold;">-0.94 (-1.70, -0.18)</span></p>
</div><br clear="all"></li></ul>
<p><span class="font0" style="font-weight:bold;">Istanbulluoglu 2009 &nbsp;&nbsp;&nbsp;2.11 1.33 &nbsp;&nbsp;&nbsp;45 &nbsp;3.48 1.68 &nbsp;&nbsp;&nbsp;45 &nbsp;&nbsp;&nbsp;9.4%</span></p>
<p><span class="font0" style="font-weight:bold;">Subtotal (95% Cl) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;113 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;108 &nbsp;20.6%</span></p>
<p><span class="font0" style="font-weight:bold;">Heterogeneity: Tau<sup>3</sup> = 0.23; Chi<sup>3</sup> = 4.34, df = 1 (P = 0.04); I<sup>3</sup> = 77% Test for overall effect: Z = 2.42 (P = 0.02)</span></p>
<div>
<p><span class="font0" style="font-weight:bold;">-0.83 (-1.22. -0.45</span></p>
</div><br clear="all">
<p><span class="font0" style="font-weight:bold;">Total (95% Cl) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;387 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;387 100.0%</span></p>
<p><span class="font0" style="font-weight:bold;">Heterogeneity: Tau<sup>3</sup> = 0.30; Chi<sup>3</sup> = 85.43, df = 9 (P &lt;&nbsp;0.00001); I<sup>3</sup> = 89% &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;---------∏----H---+----+----+-----</span></p>
<p><span class="font0" style="font-weight:bold;">Test for overall effect: Z ≈ 4.28 (P &lt;&nbsp;0.0001) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Favours [experimental] Favours [control]</span></p>
<p><span class="font0" style="font-weight:bold;">Test for Suborouo differences: Chl = 0.09. df = 1 (P = 0.77). I = 0%</span></p>
<p><span class="font6" style="font-weight:bold;">Gambar 2. </span><span class="font6" style="font-style:italic;">Forest plot</span><span class="font6"> menunjukkan lama rawat (hari) pada prosedur (eksperimental) dibandingkan dengan nefrostomi (kontrol)</span></p>
<div>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Experimental &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C</span></p></td><td colspan="2" style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">ontrol</span></p></td><td rowspan="2" style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">Weight</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">StudyorSubgroup Mean SD Total Mean</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">SD</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Total</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.2.1 Tubeless vs Nephrostomy Tube</span></p></td><td colspan="3" style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">Agrawal 2008 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.36 0.2 101 0.39</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">0.17</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">101</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">85.4%</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Lu 2012 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.91 0.62 &nbsp;&nbsp;&nbsp;16 2.14</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.51</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">16</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.4%</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Mishra 2010 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.6 0.9 &nbsp;&nbsp;&nbsp;11 &nbsp;&nbsp;&nbsp;1.6</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.7</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">11</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.5%</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Shah 2008 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.44 0.46 &nbsp;&nbsp;&nbsp;33 &nbsp;&nbsp;0.5</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.08</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">32</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.4%</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Shoma 2012 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.9 1.7 &nbsp;&nbsp;&nbsp;50 &nbsp;&nbsp;2.4</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">1.7</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">50</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.5%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">Tefekli 2007 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.7 0.6 &nbsp;&nbsp;&nbsp;17 &nbsp;&nbsp;&nbsp;1.3</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">0.2</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">18</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">2.5%</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Subtotal (95% CI) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;228</span></p>
<p><span class="font0" style="font-weight:bold;">Heterogeneity: Chi<sup>2</sup> = 10.78, df = 5 (P = 0.06); I<sup>2</sup></span></p>
<p><span class="font0" style="font-weight:bold;">Test for overall effect: Z = 0.97 (P = 0.33)</span></p></td><td style="vertical-align:middle;">
<p><span class="font0" style="font-weight:bold;">= 54%</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">228</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">91.7%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">1.2.2 Totally Tubeless vs Nephrostomy Tube</span></p></td><td colspan="3" style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">ChangZOll &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.92 0.52 &nbsp;&nbsp;68 2.02</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">0.53</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">63</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">6.9%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">Istanbulluoglu 2009 &nbsp;&nbsp;&nbsp;1.59 0.96 &nbsp;&nbsp;&nbsp;45 1.63</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">1.01</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">45</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">1.4%</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Subtotal (9S% Cl) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;113</span></p>
<p><span class="font0" style="font-weight:bold;">Heterogeneity: Chi<sup>3</sup> = 0.07, df = 1 (P = 0.79); I<sup>3</sup> =</span></p>
<p><span class="font0" style="font-weight:bold;">Test for overall effect: Z= 1.07 (P = 0.28)</span></p></td><td style="vertical-align:middle;">
<p><span class="font0" style="font-weight:bold;">0%</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">108</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">8.3%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">Total (95% Cl) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;341</span></p>
<p><span class="font0" style="font-weight:bold;">Heterogeneity: Chi<sup>2</sup> = 11.42, df - 7 (P - 0.12); I<sup>2</sup></span></p>
<p><span class="font0" style="font-weight:bold;">Test for overall effect: Z = 1.23 (P = 0.22)</span></p></td><td style="vertical-align:middle;">
<p><span class="font0" style="font-weight:bold;">= 39%</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">336</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">100.0%</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Test for subgroup differences: Chi<sup>2</sup> = 0.56. df = 1</span></p></td><td colspan="2" style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">(P = 0.45). I<sup>2</sup></span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">= 0%</span></p></td></tr>
</table>
<p><span class="font0" style="font-weight:bold;">-0.10 [-0.28. 0.08)</span></p>
<p><span class="font0" style="font-weight:bold;">-0.04 (-0.45, 0.37)</span></p>
<p><span class="font0" style="font-weight:bold;">-0.09 [-0.25, 0.07]</span></p>
</div><br clear="all">
<div>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Mean Difference &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mean Di</span></p>
<p><span class="font0" style="font-weight:bold;">IV, Fixed, 95% Cl &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IV<sub>l</sub>Fixed</span></p>
<p><span class="font0" style="font-weight:bold;">-0.03 [-0.08, 0.02) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">fference , 95% Cl</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">-0.23 [-0.62, 0.16)</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">0.00 [-0.67, 0.67)</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">-0.06 [-0.47, 0.35) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>,</sup></span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td rowspan="2" style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">-0.50 [-1.17, 0.17)</span></p>
<p><span class="font0" style="font-weight:bold;">0.40 [0.10, 0.70)</span></p>
<p><span class="font0" style="font-weight:bold;">-0.02 [-0.07, 0.03] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td></tr>
</table>
</div><br clear="all">
<div><img src="https://jurnal.harianregional.com/media/64333-7.jpg" alt="" style="width:39pt;height:22pt;">
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;">-0.03 [-0.08, 0.02]</span></p>
<p><span class="font0" style="font-weight:bold;">-------1------------1----------------------1------------F</span></p>
<p><span class="font0" style="font-weight:bold;">-1 &nbsp;&nbsp;&nbsp;-0.5 &nbsp;&nbsp;&nbsp;0 &nbsp;&nbsp;&nbsp;&nbsp;0.5 &nbsp;&nbsp;&nbsp;&nbsp;1</span></p>
<p><span class="font0" style="font-weight:bold;">Favours [experimental) Favours [control]</span></p>
</div><br clear="all">
<p><span class="font6" style="font-weight:bold;">Gambar 3. </span><span class="font6" style="font-style:italic;">Forest plot</span><span class="font6"> menunjukkan penurunan Hb (gr/dL) pada prosedur (eksperimental) dibandingkan dengan nefrostomi (kontrol)</span></p>
<p><span class="font6">tidak adanya perbedaan yang signifikan dalam hal</span></p>
<p><span class="font6">Tidak ada studi yang melaporkan &nbsp;&nbsp;&nbsp;penurunan Hb antara grup t</span><span class="font6" style="font-style:italic;">ubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally</span></p>
<p><span class="font6">perbedaan yang signifikan pada angka penurunan &nbsp;&nbsp;&nbsp;</span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dibandingkan dengan grup nefrostomi. Hal</span></p>
<p><span class="font6">yang serupa juga ditunjukkan pada analisis subgrup.</span></p>
<p><span class="font6">sederhana, prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless </span><span class="font6">merupakan pilihan tindakan yang relatif aman.</span></p>
<div>
<table border="1">
<tr><td rowspan="2" style="vertical-align:bottom;">
<p><span class="font0">Study or Subgroup</span></p></td><td colspan="3" style="vertical-align:bottom;">
<p><span class="font0">Tubeless</span></p></td><td colspan="3" style="vertical-align:bottom;">
<p><span class="font0">Nephrostomy Tube</span></p></td><td colspan="2" style="vertical-align:bottom;">
<p><span class="font0">Mean Difference</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0">Mean</span></p></td><td style="vertical-align:top;">
<p><span class="font0">SD</span></p></td><td style="vertical-align:top;">
<p><span class="font0">Total</span></p></td><td style="vertical-align:top;">
<p><span class="font0">Mean</span></p></td><td style="vertical-align:top;">
<p><span class="font0">SD</span></p></td><td style="vertical-align:top;">
<p><span class="font0">Total</span></p></td><td style="vertical-align:top;">
<p><span class="font0">Weight</span></p></td><td style="vertical-align:top;">
<p><span class="font0">IV, Random, 95% Cl</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0">Desai 2004</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">87.5</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">55.8</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">10</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">217.5</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">59</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">10</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">24.0%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">-130.00 [-180.33, -79.67]</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0">Shah 2008</span></p></td><td style="vertical-align:top;">
<p><span class="font0">150</span></p></td><td style="vertical-align:top;">
<p><span class="font0">97.42</span></p></td><td style="vertical-align:top;">
<p><span class="font0">33</span></p></td><td style="vertical-align:top;">
<p><span class="font0">246.1</span></p></td><td style="vertical-align:top;">
<p><span class="font0">167.4</span></p></td><td style="vertical-align:top;">
<p><span class="font0">32</span></p></td><td style="vertical-align:top;">
<p><span class="font0">20.5%</span></p></td><td style="vertical-align:top;">
<p><span class="font0">-96.10 [-162.95, -29.25]</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0">Shoma 2012</span></p></td><td style="vertical-align:top;">
<p><span class="font0">30</span></p></td><td style="vertical-align:top;">
<p><span class="font0">48</span></p></td><td style="vertical-align:top;">
<p><span class="font0">50</span></p></td><td style="vertical-align:top;">
<p><span class="font0">57</span></p></td><td style="vertical-align:top;">
<p><span class="font0">58</span></p></td><td style="vertical-align:top;">
<p><span class="font0">50</span></p></td><td style="vertical-align:top;">
<p><span class="font0">29.4%</span></p></td><td style="vertical-align:top;">
<p><span class="font0">-27.00 [-47.87, -6.13]</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0">Tefekli 2007</span></p></td><td style="vertical-align:top;">
<p><span class="font0">110.3</span></p></td><td style="vertical-align:top;">
<p><span class="font0">52.2</span></p></td><td style="vertical-align:top;">
<p><span class="font0">17</span></p></td><td style="vertical-align:top;">
<p><span class="font0">200</span></p></td><td style="vertical-align:top;">
<p><span class="font0">66.1</span></p></td><td style="vertical-align:top;">
<p><span class="font0">18</span></p></td><td style="vertical-align:top;">
<p><span class="font0">26.2%</span></p></td><td style="vertical-align:top;">
<p><span class="font0">-89.70 [-129.05, -50.35]</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0">Total (95% Cl)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font0">110</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font0">110</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">100.0%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">-82.26 [-134.49, -30.02]</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0">Heterogeneity: Tau<sup>j</sup> =</span></p></td><td colspan="2" style="vertical-align:bottom;">
<p><span class="font0">2306.13. Chi’ :</span></p></td><td colspan="4" style="vertical-align:bottom;">
<p><span class="font0">= 19.88, df = 3 (P = 0.0002); I<sup>i</sup></span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">= 85%</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0">Test for overall effect<sup>-</sup></span></p></td><td colspan="3" style="vertical-align:top;">
<p><span class="font0">Z = 3.09 (P = 0.002)</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
</table>
</div><br clear="all">
<div>
<p><span class="font0">Mean Difference</span></p>
<p><span class="font0" style="font-weight:bold;">IV, Random, 95% Cl</span></p>
</div><br clear="all">
<div><img src="https://jurnal.harianregional.com/media/64333-8.jpg" alt="" style="width:120pt;height:55pt;">
<p><span class="font0">Favours [Tubeless] Favours [Nephrostomy]</span></p>
</div><br clear="all">
<p><span class="font6" style="font-weight:bold;">Gambar 4. </span><span class="font6">Forest plot menunjukkan kebutuhan analgesia (Diclofenac) dalam mg pada prosedur </span><span class="font6" style="font-style:italic;">tubeless </span><span class="font6">dibandingkan dengan nefrostomi</span></p>
<p><span class="font6">Sebanyak 8 studi membandingkan kebutuhan analgesia pasca-operasi pada grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dibandingkan dengan grup nefrostomi.<sup>4-6,8-11,14</sup> Dari delapan studi tersebut, sebanyak 5 studi melaporkan bahwa grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> memerlukan lebih sedikit analgesia dibandingkan dengan grup nefrostomi pasca PNL.<sup>4,9-11,14</sup> Empat studi dianalisis dalam meta analisis ini karena terdapat satu studi yang tidak melaporkan standar deviasi serta penggunaan tipe analgesia yang berbeda.<sup>6,9-11 </sup>Studi meta analisis ini menunjukkan bahwa grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> memerlukan lebih sedikit analgesia dibandingkan dengan grup nefrostomi.</span></p>
<p><span class="font6">Studi meta analisis ini menunjukkan keunggulan antara prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dibandingkan dengan prosedur nefrostomi pasca tindakan PNL. Lebih singkatnya rawat inap diasosiasikan dengan lebih cepatnya pasien kembali ke aktivitas normal dan hal ini juga dapat menekan biaya yang diperlukan. Lebih sedikitnya kebutuhan akan analgesia diharapkan angka nyeri dan ketidaknyamanan pasien pasca operasi juga lebih rendah. Namun disisi lain, pemasangan DJ stent pada grup </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> juga memiliki kekurangan yaitu dibutuhkan prosedur tambahan untuk melepaskan stent di waktu berikutnya, ditambah lagi pasien juga akan merasakan disuria dan gejala-gejala iritatif. Hal-hal ini tidak akan ditemukan pada grup </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6">. Perbaikan-perbaikan prosedur ini masih berjalan dimana banyak literatur melaporkan teknik tambahan untuk meningkatkan hemostasis seperti penggunaan elektrokauter, fulgurasi pada </span><span class="font6" style="font-style:italic;">track</span><span class="font6"> PNL, serta penggunaan beberapa agen untuk menghentikan perdarahan.<sup>16-</sup></span><span class="font3">20-</span></p>
<p><span class="font6">Pedoman tatalaksana tindakan yang dikeluarkan oleh </span><span class="font6" style="font-style:italic;">European Urological Association </span><span class="font6">(EAU) menyarankan bahwa pada kasus yang </span><a href="https://ojs.unud.ac.id/index.php/eum"><span class="font6">https://ojs.unud.ac.id/index.php/eum</span></a><span class="font6"> doi:10.24843.MU.2020.V9.i10.P01</span></p>
<p><span class="font6">Rekomendasi yang dikeluarkan oleh asosiasi ini untuk prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> adalah rekomendasi tingkat A dimana rekomendasi ini berdasarkan studi klinis dengan kualitas yang baik.<sup>3</sup></span></p>
<p><span class="font6">Penelitian meta analisis ini menggunakan 11 studi RCTs sehingga diharapkan analisis-analisis yang disajikan akan representatif dan mengurangi kerancuan. Penelitian meta analisis ini juga memiliki beberapa kekurangan, yaitu kurangnya studi RCTs dalam hal luaran prosedur </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dan nefrostomi yang dapat dianalisis. Pada meta analisis ini penulis hanya menganalisis dua studi terkait perbandingan luaran prosedur </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dan nefrostomi pasca PNL. Lebih lanjut, penulis tidak dapat menganalisis perbandingan kebutuhan analgesia karena tidak ada data yang bisa dibandingkan. Kekurangan lainnya adalah heterogenitas data yang masih cukup tinggi yang penulis coba untuk kurangi dengan cara melakukan analisis subgrup. Studi-studi RCTs dengan kualitas yang baik dan subyek yang lebih banyak masih sangat diperlukan yang berkaitan dengan luaran prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> dibandingkan dengan nefrostomi pasca PNL.</span></p>
<p><span class="font6" style="font-weight:bold;">SIMPULAN</span></p>
<p><span class="font6">Studi meta analisis ini menunjukkan bahwa prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> dan </span><span class="font6" style="font-style:italic;">totally tubeless</span><span class="font6"> pasca PNL diasosiasikan dengan lebih singkatnya lama rawat inap dibandingkan dengan prosedur nefrostomi pasca PNL. Prosedur </span><span class="font6" style="font-style:italic;">tubeless</span><span class="font6"> juga berasosiasi dengan lebih sedikitnya kebutuhan analgesia dibandingkan dengan prosedur nefrostomi pasca PNL.</span></p>
<p><span class="font6" style="font-weight:bold;">DAFTAR PUSTAKA</span></p>
<ul style="list-style:none;"><li>
<p><span class="font6">1. &nbsp;&nbsp;&nbsp;Williams SK, Hoenig DM. Synchronous bilateral percutaneous nephrostolithotomy. </span><span class="font6" style="font-style:italic;">J Endourol.</span><span class="font6"> 2009;23(10):1707-1712.</span></p></li>
<li>
<p><span class="font6">2. &nbsp;&nbsp;&nbsp;Wong MYC. An update on percutaneous nephrolithotomy in the management of urinary stone. </span><span class="font6" style="font-style:italic;">Curr Opin Urol.</span><span class="font6"> 2001;11:367-372.</span></p></li>
<li>
<p><span class="font6">3. &nbsp;Turk &nbsp;C, Knoll T, Petrik A, Sarica K,</span></p></li></ul>
<p><span class="font6">Skolarikos A, Straub M, et al. Guidelines on urolithiasis. </span><span class="font6" style="font-style:italic;">European Association of Urology Guidelines</span><span class="font6">. 2015.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font6">4. &nbsp;&nbsp;&nbsp;Agrawal MS, Agrawal M, Gupta A, Bansal S, Yadav A, Goyal J. A randomized comparison of tubeless and standard percutaneous nephrolithotomy. </span><span class="font6" style="font-style:italic;">J Endourol</span><span class="font6">. 2008;22(3):439-442.</span></p></li>
<li>
<p><span class="font6">5. &nbsp;&nbsp;&nbsp;Choi M, Brusky J, Weaver J, Amantia M, Bellman GC. Randomized trial comparing modified &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;tubeless &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;percutaneous</span></p></li></ul>
<p><span class="font6">nephrolithotomy with tailed stent with percutaneous nephrostomy with small-bore tube. </span><span class="font6" style="font-style:italic;">J Endourol</span><span class="font6">. 2006;20(10):766-770.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font6">6. &nbsp;&nbsp;&nbsp;Desai MR, Kukreja RA, Desai MM, Mhaskar SS, Wani KA, Patel SH, et al. A prospective randomized comparison of type of nephrostomy drainage following percutaneous nephrostolithotomy: large bore versus small bore versus tubeless. </span><span class="font6" style="font-style:italic;">J Urol</span><span class="font6">. 2004;172:565-567.</span></p></li>
<li>
<p><span class="font6">7. &nbsp;&nbsp;&nbsp;Marchant F, Recabal P, Fernandez MI, Osorio F, Benavides J. Postoperative morbidity of tubeless versus conventional percutaneous nephrolithotomy. </span><span class="font6" style="font-style:italic;">Urol Res</span><span class="font6">. 2011;39:477-481.</span></p></li>
<li>
<p><span class="font6">8. &nbsp;&nbsp;&nbsp;Mishra S, Sabnis RB, Kurien A, Ganpule A, Muthu V, Desai M. Questioning the wisdom of tubeless percutaneous nephrolithotomy (PCNL): a prospective randomized controlled study of early tube removal vs tubeless PCNL. </span><span class="font6" style="font-style:italic;">BJU Int</span><span class="font6">. 2010;106:1045-1049.</span></p></li>
<li>
<p><span class="font6">9. &nbsp;&nbsp;&nbsp;Shah HN, Sodha HS, Khandkar AA, Kharodawala S, Hegde SS, Bansal MB. A randomized trial evaluating type of nephrostomy drainage after percutaneous nephrolithotomy: small bore v tubeless. </span><span class="font6" style="font-style:italic;">J Endourol</span><span class="font6">. 2008;22(7):1433-1439.</span></p></li>
<li>
<p><span class="font6">10. &nbsp;&nbsp;&nbsp;Shoma AM, Elshal AM. Nephrostomy tube placement after percutaneous nephrolithotomy: critical evaluation through a prospective randomized study. </span><span class="font6" style="font-style:italic;">Urology</span><span class="font6">. 2012;79:771-776.</span></p></li>
<li>
<p><span class="font6">11. &nbsp;&nbsp;&nbsp;Tefekli A, Altunrende F, Tepeler K, Tas A, Aydin S, Muslumanoglu AY. Tubeless percutaneous nephrolithotomy in selected patients: &nbsp;&nbsp;&nbsp;a prospective randomized</span></p></li></ul>
<p><span class="font6">comparison. </span><span class="font6" style="font-style:italic;">Int Urol Nephrol</span><span class="font6">. 2007;39:57-63.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font6">12. &nbsp;&nbsp;&nbsp;Lu Y, Ping JG, Zhao XJ, Hu LK, Pu JX. Randomized prospective trial of tubeless versus conventional minimally invasive percutaneous nephrolithotomy. </span><span class="font6" style="font-style:italic;">World J Urol</span><span class="font6">. 2012.DOI 10.1007/s00345-012-0921-2.</span></p></li>
<li>
<p><span class="font6">13. &nbsp;&nbsp;&nbsp;Chang CH, Wang CJ, Huang SW. Totally tubeless percutaneous nephrolithotomy: a prospective randomized controlled study. </span><span class="font6" style="font-style:italic;">Urol Res</span><span class="font6">. 2011;39:459-465.</span></p></li>
<li>
<p><span class="font6">14. &nbsp;&nbsp;&nbsp;Istanbulluoglu MO, Ozturk B, Gonen M, Cicek T, Ozkardes H. Effectiveness of totally tubeless percutaneous nephrolithotomy in selected patients: a prospective randomized study. </span><span class="font6" style="font-style:italic;">Int Urol Nephrol</span><span class="font6">. 2009;41:541-545.</span></p></li>
<li>
<p><span class="font6">15. &nbsp;&nbsp;&nbsp;Probst CEM, Denstedt JD, Razvi H. Preoperative indications for percutaneous nephrolithotripsy in 2009. </span><span class="font6" style="font-style:italic;">J Endourol</span><span class="font6">. 2009;23:1557-1561.</span></p></li>
<li>
<p><span class="font6">16. &nbsp;&nbsp;&nbsp;Singh I, Saran RN, Jain M. Does sealing of the tract with absorbable gelatin (Spongostan), facilitate tubeless PCNL? A prospective study. </span><span class="font6" style="font-style:italic;">J Endourol</span><span class="font6">. 2008;22:2485-2493.</span></p></li>
<li>
<p><span class="font6">17. &nbsp;&nbsp;&nbsp;Shah HN, Hegde S, Shah JN, Mohile PD, Yuvaraja TB, Bansal MB. A prospective, randomized trial evaluating the safety and efficacy of fibrin sealant in &nbsp;&nbsp;tubeless</span></p></li></ul>
<p><span class="font6">percutaneous nephrolithotomy. </span><span class="font6" style="font-style:italic;">J &nbsp;&nbsp;Urol</span><span class="font6">.</span></p>
<p><span class="font6">2006;176(6):2488-2493.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font6">18. &nbsp;&nbsp;&nbsp;Aghamir SM, Khazaeli MH, Meisami A. Use of Surgicel for sealing nephrostomy tract after totally tubeless percutaneous nephrolithotomy. </span><span class="font6" style="font-style:italic;">J Endourol</span><span class="font6">. 2006;20:293-295.</span></p></li>
<li>
<p><span class="font6">19. &nbsp;&nbsp;&nbsp;Aron M, Goel R, Kesarwani PK, Gupta NP. Hemostasis in tubeless PNL: &nbsp;Point of</span></p></li></ul>
<p><span class="font6">technique. </span><span class="font6" style="font-style:italic;">Urol Int</span><span class="font6">. 2004;73:244-247.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font6">20. &nbsp;&nbsp;&nbsp;Jou YC, Cheng MC, Sheen JH, Lin CT, Chen PC. Electrocauterization of bleeding points for percutaneous nephrolithotomy. </span><span class="font6" style="font-style:italic;">Urology</span><span class="font6">. 2004;64(3):443-446</span></p></li></ul>
<p><a href="https://ojs.unud.ac.id/index.php/eum"><span class="font6">https://ojs.unud.ac.id/index.php/eum</span></a></p>
<p><span class="font6">doi:10.24843.MU.2020.V9.i10.P01</span></p>
<p><span class="font6" style="font-weight:bold;">7</span></p>